Jacquemyn Xander, Bamps Kobe, Moermans Ruben, Dubois Christophe, Rega Filip, Verbrugghe Peter, Weyn Barbara, Dymarkowski Steven, Budts Werner, Van De Bruaene Alexander
KU Leuven, Department of Cardiovascular Sciences, Leuven, Belgium.
University Hospitals Leuven, Division of Cardiology, Leuven, Belgium.
J Med Imaging (Bellingham). 2024 Nov;11(6):062606. doi: 10.1117/1.JMI.11.6.062606. Epub 2024 Oct 8.
Virtual reality (VR) and augmented reality (AR) have led to significant advancements in cardiac preoperative planning, shaping the world in profound ways. A noticeable gap exists in the availability of a comprehensive multi-user, multi-device mixed reality application that can be used in a multidisciplinary team meeting.
A multi-user, multi-device mixed reality application was developed, supporting AR and VR implementations. Technical validation involved a standardized testing protocol and comparison of AR and VR measurements regarding absolute error and time. Preclinical validation engaged experts in interventional cardiology, evaluating the clinical applicability prior to clinical validation. Clinical validation included patient-specific measurements for five patients in VR compared with standard computed tomography (CT) for preoperative planning. Questionnaires were used at all stages for subjective evaluation.
Technical validation, including 106 size measurements, demonstrated an absolute median error of 0.69 mm (0.25 to 1.18 mm) compared with ground truth. The time to complete the entire task was on average, with VR measurements being faster than AR ( versus , ). On clinical validation of five preoperative patients, there was no statistically significant difference between paired CT and VR measurements (0.58 [95% CI, to 2.74], ). Questionnaires showcased unanimous agreement on the user-friendly nature, effectiveness, and clinical value.
The mixed reality application, validated through technical, preclinical, and clinical assessments, demonstrates precision and user-friendliness. Further research of our application is needed to validate the generalizability and impact on patient outcomes.
虚拟现实(VR)和增强现实(AR)已在心脏术前规划方面取得显著进展,以深远的方式塑造着这个世界。在可用于多学科团队会议的综合性多用户、多设备混合现实应用的可用性方面,存在明显差距。
开发了一种多用户、多设备混合现实应用,支持AR和VR实现。技术验证涉及标准化测试协议以及AR和VR测量在绝对误差和时间方面的比较。临床前验证邀请了介入心脏病学专家,在临床验证之前评估临床适用性。临床验证包括对五名患者进行VR中的特定患者测量,并与术前规划的标准计算机断层扫描(CT)进行比较。在所有阶段都使用问卷调查进行主观评估。
技术验证包括106次尺寸测量,与真实值相比,绝对中位数误差为0.69毫米(0.25至1.18毫米)。完成整个任务的平均时间为 ,VR测量比AR更快( 对 , )。在对五名术前患者的临床验证中,配对的CT和VR测量之间没有统计学上的显著差异(0.58 [95% CI, 至2.74], )。问卷调查显示在用户友好性、有效性和临床价值方面达成了一致意见。
通过技术、临床前和临床评估验证的混合现实应用展示了精确性和用户友好性。需要对我们的应用进行进一步研究,以验证其普遍性以及对患者预后的影响。